Add BrightSurf on Google Email

Sequencing of the developing human brain uncovers hundreds of thousands of new gene transcripts

A recent study has cataloged gene-isoform variation in the developing human brain, providing crucial insights into neurodevelopmental and psychiatric disorders. The research found thousands of isoform switches that occur during brain development, implicating previously uncharacterized RNA-binding proteins.

SourceUniversity of California - Los Angeles Health Sciences·JournalScience·TypeImaging analysis·DateMay 23, 2024

New study highlights importance of screening for rare inherited iron metabolism defects

Researchers evaluated anemia cases using stringent clinical and laboratory criteria, identifying rare congenital sideroblastic anemias and nonsideroblastic iron defects with pathogenic gene mutations. This study highlights the importance of active screening and awareness for these conditions in the Indian subcontinent.

SourceElsevier·JournalJournal of Molecular Diagnostics·TypeExperimental study·DateMay 20, 2024

Gilbert Family Foundation invests $21 million to launch new research initiative focused on developing advanced disease models to accelerate cure for neurofibromatosis

The Gilbert Family Foundation has invested $21 million in grants to launch the Next-Generation NF1 Models Initiative, a research program focused on developing advanced models of the NF1 disease. The initiative aims to accelerate the discovery of treatments that address both symptoms and underlying causes of neurofibromatosis.

Study implicates Neanderthal DNA in autism susceptibility

Researchers at Clemson University discovered that certain Neanderthal-derived genetic variations are more common in people with autism than in the general population. These findings suggest long-term effects of ancient human hybridization on brain organization and function, potentially leading to earlier diagnostics.

SourceClemson University·JournalMolecular Psychiatry·TypeData/statistical analysis·DateMay 17, 2024

After 25 years, researchers uncover genetic cause of rare neurological disease

Scientists have identified the genetic mutation that causes SCA4, a progressive neurological disorder. The mutated gene ZFHX3 leads to impaired protein recycling in nerve cells, causing symptoms such as difficulty walking and balancing. This discovery opens the door to potential treatments for both SCA4 and another related form of ataxia.

SourceUniversity of Utah Health·JournalNature Genetics·TypeExperimental study·DateApr 29, 2024

Gene-based therapy restores cellular development and function in brain cells from people with Timothy syndrome

Researchers developed a gene-based therapy that restored typical cellular function in organoids created from cells of people with Timothy syndrome. The treatment used antisense oligonucleotides to decrease the use of mutated exon 8A and increase reliance on non-affected exon 8, restoring normal calcium channel functioning.

A new Spanish study provides the first stratification of the risk of developing dilated cardiomyopathy among symptom-free genetic carriers

A new Spanish study provides the first stratification of the risk of developing dilated cardiomyopathy among symptom-free genetic carriers. Researchers found that nearly 11% of genetic carriers developed the disease within a median follow-up period of 37 months.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalJournal of the American College of Cardiology·TypeObservational study·DateApr 22, 2024

Mosaics of predisposition cause skin disease

Researchers at Kobe University discovered a new gene, FDFT1, responsible for porokeratosis by identifying epigenetic silencing. Patients with localized lesions didn't have inherited damaged copies, leading to a hypothesis that epigenetic changes are the first hit. The findings have implications for treatment and counseling.

SourceKobe University·JournalThe American Journal of Human Genetics·TypeObservational study·DateApr 22, 2024

Examining sex differences in autism heritability

A study of over 1 million Swedish children reveals that genetic differences contribute to phenotypic variation in autism spectrum disorder, differing significantly between males and females. The findings suggest underlying causes of autism may differ between the sexes, partly explaining the skewed sex ratio in the condition.

SourceJAMA Network·JournalJAMA Psychiatry·DateApr 17, 2024

Cause of rare genetic condition discovered

Researchers have identified a rare genetic condition, Glutamine Synthetase Stabilization Disorder, which causes seizures and delayed development. The study found that genetic variants increase the stability of an enzyme producing glutamine, disrupting brain development.

SourceUniversity of Otago·JournalAmerican Journal of Human Genetics·DateApr 14, 2024

Genetic analysis reveals true origin of chronic kidney disease in undiagnosed patients

Researchers discovered that known genetic variants account for a large portion of chronic kidney diseases with unknown origin. The study found that 10% of patients had pathogenic variants in CKD-causing genes, and some hereditary renal diseases could be diagnosed and treated early on to slow down disease progression.

SourceTokyo Medical and Dental University·JournalKidney International Reports·DateApr 3, 2024

New study maps a group of rare genetic diseases for the first time

A new study from Aarhus University reveals that only 67% of Danes registered with an ectodermal dysplasia diagnosis actually have congenital ectodermal dysplasia. The study identifies key characteristics, including abnormal teeth, skin issues, and nail problems, highlighting the need for collaboration across healthcare disciplines.

SourceAarhus University·JournalJAMA Dermatology·TypeSystematic review·DateApr 2, 2024

‘Exhausted’ immune cells in healthy women could be target for breast cancer prevention

A study published in Nature Genetics reveals early cell changes in healthy carriers of BRCA1 and BRCA2 gene mutations, suggesting a potential target for breast cancer prevention. The researchers created the world's largest catalogue of human breast cells, which may lead to the use of existing immunotherapy drugs as an early intervention.

SourceUniversity of Cambridge·JournalNature Genetics·DateMar 28, 2024

Two new mutations identified as possible causes of rare blood disorder

Researchers discovered two novel GNE gene mutations that may cause a rare blood disorder called macrothrombocytopenia. The mutations affect the synthesis of sialic acid, critical for brain development and angiogenesis. Further studies are needed to understand the mechanism underlying this disorder and explore therapeutic interventions.

How genes work together to shape how much you smoke

A recent study by University of Colorado Boulder researchers sheds light on the interactions between genetic variants and their impact on smoking behaviors. The study found that certain gene variants can interact with each other and with Mr. Big, a widely replicated genetic variant associated with smoking behaviors.

SourceUniversity of Colorado at Boulder·JournalDrug and Alcohol Dependence·TypeData/statistical analysis·DateMar 26, 2024

ALG6 acts as a modifier gene in the inherited genetic eye disease retinitis pigmentosa 59

Researchers at the University of Alabama at Birmingham discovered that the ALG6 variant is associated with altered phenotypes in patients with RP59, including delayed peripheral rod degeneration and diminished macular cone photoreceptor health. This study highlights the complex effects of modifier genes in human genetic disease.

SourceUniversity of Alabama at Birmingham·JournalInternational Journal of Molecular Sciences·TypeMeta-analysis·DateMar 20, 2024

Scientists use an innovative approach to provide relevant insights into a rare neurologic disorder

Researchers have discovered new genetic mechanisms related to spinocerebellar ataxia type 37, a rare neurological disorder that affects balance and movement. The study employed advanced techniques such as CRISPR/Cas9 gene editing and machine learning to uncover the disease's underlying causes.

SourceGermans Trias i Pujol Research Institute·JournalHuman Genetics·TypeExperimental study·DateMar 14, 2024

Study reveals key mechanisms of rare form of epilepsy

A study identifies a genetic mutation underlying KCNQ2 encephalopathy, a rare and devastating form of epilepsy. The research reveals key mechanisms by which the disorder manifests in patients, including suppression of normal gene function and altered protein distribution.

SourceeLife·JournaleLife·DateMar 12, 2024

Why some RNA drugs work better than others

Researchers have discovered why some RNA-splicing drugs work better than others, revealing a key factor that impacts treatment efficacy. By analyzing the interactions between drugs and RNA, they found that combining splice-modifying drugs targeting the same gene segment can lead to greater therapeutic effects.

SourceCold Spring Harbor Laboratory·JournalNature Communications·DateMar 6, 2024

Overcoming barriers to conducting clinical trials in childhood rare disease research

A team of scientists at The Hospital for Sick Children developed an innovative statistical approach to demonstrate the effectiveness of a medication in reducing disease progression and liver transplants in children with Alagille syndrome. Using data from an international real-world cohort, they found a 70% improvement in event-free sur...

SourceThe Hospital for Sick Children·JournalHepatology·DateFeb 29, 2024

Journal of Pharmaceutical Analysis articles provide novel insights into previously unknown disease mechanisms

Researchers decode underlying mechanisms of DCM, hippocampal neurotoxicity, and dysbiosis mediated AD progression using mass spectrometry imaging. The studies found metabolic changes in DCM rat hearts and regulation of CYPs in the hippocampus, providing new perspectives on treatment strategies.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateFeb 26, 2024

Unlocking health: How In Our DNA SC is pioneering genetic screening for South Carolinians

A statewide genomic screening program enrolls first 20,000 participants, providing information on genetic risk factors for diseases such as hereditary breast and ovarian cancer. The program aims to empower communities to understand the value of research and increase participation rates among underrepresented groups.

SourceMedical University of South Carolina·JournalAmerican Journal of Human Genetics·TypeExperimental study·DateFeb 23, 2024

Predicting neurodevelopmental disease in children from parent’s traits

Researchers found that parents' manifestation of neurodevelopmental and psychiatric traits can predict the prevalence and severity of disorders in children. The study analyzed 97,000 families and revealed a correlation between parental traits, suggesting that assortative mating may contribute to increased disease severity.

SourcePenn State·JournalAmerican Journal of Human Genetics·TypeData/statistical analysis·DateFeb 7, 2024

Gene-based therapy may slow development of life-threatening heart condition

Researchers have found that a gene-based therapy targeting plakophilin-2 can interrupt the progression of arrhythmogenic right ventricular cardiomyopathy, a rare inherited disorder. The treatment reduced episodes of arrhythmia and slowed the deterioration of the heart's walls in mice.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalCirculation Genomic and Precision Medicine·TypeExperimental study·DateJan 30, 2024

A neurological disease paradigm shift

Researchers at McGill University propose a new biological classification system for Parkinson's disease, considering alpha-synuclein, neurodegeneration, and genetics. This shift in thinking aims to diagnose the disease earlier, targeting specific patient groups with more common biology, improving treatment development success.

SourceMcGill University·JournalThe Lancet Neurology·TypeSystematic review·DateJan 23, 2024

Off-label use of a common antibiotic to treat muscular dystrophy

Researchers from Osaka University have identified erythromycin as a potential treatment for myotonic dystrophy type 1, a genetic disease characterized by progressive muscular weakness. The antibiotic showed acceptable safety and tolerability profiles in a phase 2 clinical trial, with some patients experiencing significant improvements ...

SourceOsaka University·JournalEClinicalMedicine·TypeRandomized controlled/clinical trial·DateDec 26, 2023